Pacer Advisors Inc. boosted its position in Proto Labs, Inc. (NYSE:PRLB - Free Report) by 44,804.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 573,874 shares of the industrial products company's stock after acquiring an additional 572,596 shares during the period. Pacer Advisors Inc. owned 2.34% of Proto Labs worth $16,855,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently modified their holdings of PRLB. Intech Investment Management LLC purchased a new stake in Proto Labs in the 3rd quarter worth approximately $232,000. Connor Clark & Lunn Investment Management Ltd. lifted its stake in Proto Labs by 217.6% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 68,403 shares of the industrial products company's stock worth $2,009,000 after acquiring an additional 46,866 shares during the period. Meeder Asset Management Inc. boosted its holdings in Proto Labs by 72.3% in the third quarter. Meeder Asset Management Inc. now owns 4,465 shares of the industrial products company's stock valued at $131,000 after acquiring an additional 1,873 shares in the last quarter. KBC Group NV boosted its holdings in Proto Labs by 69.3% in the third quarter. KBC Group NV now owns 1,541 shares of the industrial products company's stock valued at $45,000 after acquiring an additional 631 shares in the last quarter. Finally, GSA Capital Partners LLP bought a new position in Proto Labs in the 3rd quarter worth $524,000. Hedge funds and other institutional investors own 84.54% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on PRLB shares. Needham & Company LLC reaffirmed a "hold" rating on shares of Proto Labs in a research note on Friday, November 1st. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $40.00 price objective on shares of Proto Labs in a research report on Monday, November 4th. Craig Hallum upped their target price on Proto Labs from $30.00 to $36.00 and gave the stock a "hold" rating in a report on Monday, November 4th. Finally, StockNews.com cut Proto Labs from a "strong-buy" rating to a "buy" rating in a research note on Monday, August 5th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $40.33.
View Our Latest Stock Analysis on Proto Labs
Insider Activity
In other news, CEO Robert Bodor acquired 3,480 shares of the firm's stock in a transaction that occurred on Friday, September 6th. The stock was bought at an average cost of $28.68 per share, for a total transaction of $99,806.40. Following the acquisition, the chief executive officer now directly owns 80,878 shares in the company, valued at approximately $2,319,581.04. The trade was a 4.50 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 1.20% of the company's stock.
Proto Labs Price Performance
NYSE:PRLB traded up $1.76 during mid-day trading on Friday, hitting $41.50. 442,557 shares of the company's stock were exchanged, compared to its average volume of 363,557. The company has a market cap of $1.02 billion, a PE ratio of 44.15 and a beta of 1.32. Proto Labs, Inc. has a one year low of $25.75 and a one year high of $41.87. The business has a fifty day moving average price of $31.36 and a 200 day moving average price of $31.10.
Proto Labs (NYSE:PRLB - Get Free Report) last issued its quarterly earnings results on Friday, November 1st. The industrial products company reported $0.47 EPS for the quarter, topping analysts' consensus estimates of $0.32 by $0.15. The firm had revenue of $125.60 million for the quarter, compared to analysts' expectations of $121.38 million. Proto Labs had a return on equity of 3.49% and a net margin of 4.76%. The business's revenue for the quarter was down 3.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.31 EPS. On average, equities analysts forecast that Proto Labs, Inc. will post 0.84 EPS for the current fiscal year.
About Proto Labs
(
Free Report)
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
See Also
Before you consider Proto Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.
While Proto Labs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.